Solid Biosciences Inc. (SLDB) Social Stream
Solid Biosciences Inc (SLDB) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering SLDB.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
SLDB's average price target has moved down $0.97 over the prior 47 weeks.
SLDB reports an average of 260.97% for its upside potential over the past 49 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
SLDB Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 22 months, SLDB's average broker recommendation rating improved by 0.21.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SLDB as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, Solid Biosciences Inc's upside potential (average analyst target price relative to current price) is greater than 392.4% of them.
- Solid Biosciences Inc's variance in analysts' estimates is lower than -278.57% of all US stocks.
- In terms of how Solid Biosciences Inc fares relative to Healthcare stocks, note that its average analyst price target is higher than 64.54% of that group.
- To contextualize these metrics, consider that out of Healthcare stocks, Solid Biosciences Inc's number of analysts covering the stock is higher than 131.29% of them.
Make investment decisions regarding SLDB using the data that counts. Try POWR Ratings for free.